
Alicia Morgans, MD, MPH, reviews the incidence of prostate cancer and risk factors associated with the disease.
Alicia Morgans, MD, MPH, reviews the incidence of prostate cancer and risk factors associated with the disease.
Clinical insights on the typical presentation of prostate cancer and how the disease is diagnosed.
Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.
Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.
An experienced public health and cancer researcher offers advice to patients newly diagnosed with prostate cancer and discusses barriers to access to care.
A genitourinary oncologist provides insights on the treatment decision-making process and the roles of guidelines for prostate cancer.
Expert perspectives on how clinical trials and real-world evidence contribute to treatment decisions in prostate cancer.
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.
Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.
A comprehensive review of treatment options for patients with metastatic hormone-sensitive prostate cancer.
An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer.
Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer.
Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.
Practical advice for improving clinical trials to ensure they are more reflective of the overall population of patients with prostate cancer.
Alicia Morgans, MD, MPH, offers advice to patients newly diagnosed with prostate cancer and reviews educational resources available for patients and their caregivers.
Reginald Tucker-Seeley, MA, ScM, ScD, concludes the program with advice for caregivers and patients with prostate cancer to maximize the benefit of treatment.